AstraZeneca gets Chinese approval for diabetes drug Xigduo XR
The once-daily fixed-dose combination has been approved for type-2 diabetes by the NMPA as an adjunct to diet…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jun 23
The once-daily fixed-dose combination has been approved for type-2 diabetes by the NMPA as an adjunct to diet…
28 Jun 23
The approval of the IgG4 monoclonal antibody is for adult patients suffering from the rare long-term autoimmune disorder…
28 Jun 23
COSBI will provide InSilicoTrials with its unique computational models and simulation tools, leveraging their expertise in systems biology…
28 Jun 23
Submissions based on positive Phase 3 data from BENEGENE-2 trial
27 Jun 23
Camzyos is an allosteric and reversible inhibitor that works by modulating the number of myosin heads that can…
27 Jun 23
The funding was led by AdBio partners, with co-syndication from M Ventures, Johnson & Johnson Innovation – JJDC…
26 Jun 23
Litfulo is said to be the first and only treatment approved by the FDA for adolescents with severe…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Jun 23
Under the partnership, both parties will start a therapeutic nutrition program that will use data from CGM technology…
26 Jun 23
Additionally, Brii Bio will acquire exclusive global rights for the development and commercialisation of the novel lipopeptide BRII-693…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Jun 23
After achieving primary endpoint by demonstrating superiority and non-inferiority in HbA1C reduction from baseline at week 52, investigative…